Silicon Laboratories (SLAB) FY2014 results: revenue $621 million, up 7.0% on the year
Silicon Laboratories Inc. (SLAB) reported revenue of $621 million for fiscal 2014, the year ended 3 January 2015, up 7.0% on the year before. Net income was $38 million, down 23.7%, and diluted earnings per share $0.87. The figures are the company's own, from the 10-K it filed with the SEC on 6 February 2015.
Revenue
$621 million
+7.0% on the year
FY2008FY2014
Operating margin
8.3%
11.1% a year earlier
FY2008FY2014
Net income
$38 million
-23.7% on the year
FY2008FY2014
Diluted EPS
$0.87
-23.7% on the year
FY2008FY2014
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Revenue
621
580
563
+7.0%
Cost of revenue
242
227
225
+6.6%
Gross profit
379
353
338
+7.3%
Gross margin
61.0%
60.8%
60.0%
Research and development
173
158
138
+9.6%
Selling, general and administrative
154
131
114
+17.9%
Operating income
51.4
64.3
85.7
-20.0%
Operating margin
8.3%
11.1%
15.2%
Interest expense
3.2
3.3
1.1
-4.2%
Pre-tax income
49.0
62.0
86.3
-20.9%
Income tax
11.0
12.2
22.8
-9.7%
Effective tax rate
22.5%
19.7%
26.4%
Net income
38.0
49.8
63.5
-23.7%
Net margin
6.1%
8.6%
11.3%
Diluted EPS
$0.87
$1.14
$1.47
-23.7%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Operating cash flow
137
120
97.0
+14.4%
Capital expenditure
11.2
10.5
102
+7.2%
Free cash flow
126
110
-5.0
+15.1%
Free cash flow margin
20.3%
18.9%
-0.9%
Depreciation and amortisation
30.5
28.1
24.3
+8.4%
Share-based compensation
39.1
30.8
31.2
+26.8%
Buybacks
71.7
26.0
62.0
+175.4%
Diluted shares, weighted
44m
44m
43m
+0.6%
Shares outstanding at period end
42m
43m
42m
-1.3%
Balance sheet
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Shareholders' equity
758
739
650
+2.6%
Debt
87.5
95.0
100
-7.9%
Other liabilities
197
158
122
+25.0%
Total liabilities and equity
1,043
991
872
+5.2%
Fixed assets
133
132
135
+0.3%
Goodwill
229
229
130
0.0%
Intangible assets
115
132
90.8
-12.6%
Investments
201
190
188
+5.6%
Cash and equivalents
142
95.8
105
+47.9%
Receivables
70.4
72.1
78.0
-2.4%
Inventory
52.6
45.3
49.6
+16.3%
Other assets
100
94.9
94.7
+5.7%
Total assets
1,043
991
872
+5.2%
10-K for the year ended 3 January 2015, filed 6 February 2015: the filing.